Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CRLF1 (135-350) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CRLF1 |
Gene ID: |
9244 |
Uniprot ID: |
CRLF1_HUMAN |
Immunogen Region: |
135-350 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 135-350 of human CRLF1 (NP_004741.1). |
Immunogen Sequence: |
PEKPVNISCWSKNMKDLTCR WTPGAHGETFLHTNYSLKYK LRWYGQDNTCEEYHTVGPHS CHIPKDLALFTPYEIWVEAT NRLGSARSDVLTLDILDVVT TDPPPDVHVSRVGGLEDQLS VRWVSPPALKDFLFQAKYQI RYRVEDSVDWKVVDDVSNQT SCRLAGLKPGTVYFVQVRCN PFGIYGSKKAGIWSEWSHPT AASTPRSERPGPGGGA |
Tissue Specificity | Highest levels of expression observed in spleen, thymus, lymph node, appendix, bone marrow, stomach, placenta, heart, thyroid and ovary. Strongly expressed also in fetal lung. |
Function | In complex with CLCF1, forms a heterodimeric neurotropic cytokine that plays a crucial role during neuronal development (Probable). May also play a regulatory role in the immune system. |
Protein Name | Cytokine Receptor-Like Factor 1Cytokine-Like Factor 1Clf-1Zcytor5 |
Database Links | Reactome: R-HSA-6788467Reactome: R-HSA-9020956 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Cytokine Receptor-Like Factor 1 antibodyAnti-Cytokine-Like Factor 1 antibodyAnti-Clf-1 antibodyAnti-Zcytor5 antibodyAnti-CRLF1 antibodyAnti-UNQ288 antibodyAnti-PRO327 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance